Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

FXHvsFHLCETF Comparison

ETF 1
FXH

First Trust Health Care AlphaDEX Fund ETF

This fund is part of
US Health Care
+1.06%
VS
ETF 2
FHLC

Fidelity MSCI Health Care Index ETF

This fund is part of
US Health Care
+1.06%

First Trust Health Care AlphaDEX Fund ETF (FXH) and Fidelity MSCI Health Care Index ETF (FHLC) belong to the same industry segment: US Health Care. FXH's top 1 sector exposures are Healthcare. In contrast, FHLC's top sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. FXH is more expensive with a Total Expense Ratio (TER) of 0.61%, versus 0.084% for FHLC. FXH is up 13.05% year-to-date (YTD) with +$32M in YTD flows. FHLC performs worse with 8.1% YTD performance, and +$268M in YTD flows. Run a side-by-side ETF comparison of FXH and FHLC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FXH vs FHLC performance and flow charts

Performance

-3.0-2.0-1.00.01.02.0%Jul 6Jul 13Jul 20Jul 27Aug 3

Cumulative Flows

-20 M0 M20 M40 M60 MJul 6Jul 13Jul 20Jul 27Aug 3

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 08/05/2026
1M3MYTD1Y3Y5Y
Perf.
FXH
FHLC
+2.11%+0.95%
+13.64%+13.85%
+13.05%+8.10%
+29.01%+28.15%
+23.93%+31.55%
+6.09%+28.30%
Flows
FXH
FHLC
+$57M+$9M
+$88M+$97M
+$32M+$268M
+$1M+$302M
-$594M-$409M
-$457M-$80M
Volatility and drawdown
3M1Y3Y5Y
Volatility
FXH
FHLC
+15.87%+17.79%
+15.83%+15.25%
+15.52%+14.45%
+16.88%+15.30%
Max drawdown
FXH
FHLC
-3.81%-3.84%
-12.07%-10.35%
-17.66%-16.88%
-29.40%-17.78%
Max drawdown duration
FXH
FHLC
20d20d
168d169d
395d435d
1759d762d
Trading data

Create an account to view trading data

Join for free
FXH
FHLC
Last sale
8/6/2026 at 6:17 PM
$127.70
$79.63
Previous close
08/05/2026
$128.30
$79.72
Consolidated volume
08/05/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of July 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
FXH
FHLC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 8/6/2026 at 6:17 PM
Live
Closed
FXH
FHLC
Last price
$127.70
$79.63
1D performance
-0.47%
-0.11%
AuM$1.08 B$3.34 B
E/R0.61%0.084%
Characteristics
FXH
FHLC
Management strategyPassivePassive
ProviderFirst TrustFidelity
BenchmarkStrataQuant Health Care IndexMSCI USA IMI Health Care 25/50 Index
N° of holdings75333
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateMay 8, 2007October 21, 2013
ESGNoNo
Advertisement
Exposure

Countries

FXH
USA
96.02%
Other
3.98%
FHLC
USA
96.98%
Other
3.02%

Sectors

FXH
Healthcare
99.85%
Other
0.15%
FHLC
Healthcare
97.66%
Other
2.34%
Advertisement

Diversification

FXH

Total weight of top 15 holdings out of 15

38.89%
FHLC

Total weight of top 15 holdings out of 15

61.21%

Top 15 holdings

Data as of June 30, 2026
FXH
Humana, Inc.
4.74%
Organon & Co.
3.63%
DaVita, Inc.
2.98%
Elevance Health, Inc.
2.86%
Molina Healthcare, Inc.
2.80%
Exelixis, Inc.
2.53%
Incyte Corp.
2.43%
Solventum Corp.
2.41%
Biogen, Inc.
2.30%
Cardinal Health, Inc.
2.26%
Bio-Rad Laboratories, Inc.
2.14%
The Cigna Group
2.09%
Chemed Corp.
2.05%
Zimmer Biomet Holdings, Inc.
1.87%
Illumina, Inc.
1.80%
FHLC
Eli Lilly & Co.
13.60%
Johnson & Johnson
8.86%
AbbVie, Inc.
6.46%
UnitedHealth Group, Inc.
5.67%
Merck & Co., Inc.
4.66%
Amgen, Inc.
2.86%
Thermo Fisher Scientific, Inc.
2.82%
Abbott Laboratories
2.44%
Gilead Sciences, Inc.
2.31%
Intuitive Surgical, Inc.
2.13%
Pfizer Inc.
2.02%
CVS Health Corp.
2.00%
Danaher Corp.
1.84%
Vertex Pharmaceuticals, Inc.
1.83%
Bristol Myers Squibb Co.
1.70%
Frequently asked questions about FXH and FHLC

How have the FXH and FHLC ETFs performed in 2026?

As of August 5, 2026, FXH is up 13.05% year-to-date (YTD), while FHLC has returned 8.1%. That puts FXH better performer ahead so far this year.

Which ETF is attracting more investor money: FXH or FHLC?

Year-to-date, the FXH ETF saw +$32M in flows, compared to +$268M for FHLC.

Which ETF is more volatile: FXH or FHLC?

Over the past year, FXH had a volatility of 15.83%, while FHLC experienced 15.25%.

Which ETF is bigger: FXH or FHLC?

As of August 5, 2026, FXH holds $1.08 B in assets under management (AUM), while FHLC manages $3.34 B.

What sectors do the FXH and FHLC ETFs invest in?

FXH leans toward sectors like Healthcare. Meanwhile, FHLC focuses on Healthcare.

What are the top holdings of the FXH ETF and FHLC ETF?

FXH top holdings include Humana, Inc., Organon & Co. and DaVita, Inc.. FHLC holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: FXH or FHLC?

FXH holds 75 securities with 38.89% of its assets in the top 15. FHLC has 337 securities and a top 15 weight of 61.21%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder